Q
QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

29,778 signal articles · 44 in last 24h · 148,396 total before filter · latest 3h ago
44last 24h
972last 7d
109● bullish (7d)
121● bearish (7d)
212publishers
AllMacro369Earnings114M&A98Regulatory8Product11Analyst9
✕ clear all filtersticker: ABTSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking
Benzinga24d agoneutral
FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking

The U.S. Food and Drug Administration (FDA) on Tuesday approved Abbott Laboratories’ (NYSE:ABT) Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for diabetes patients aged two and older. The regulatory nod makes the device the first wearable in the U.S. to monitor ketone levels continuously. It also represents the first global system to track blood sugar and ketones simultaneously within a single unit. Clinical Data And De Novo Pathway The agency granted marketing authorization